Studies on rare diseases require interdisciplinary collaboration, as is recognized. This collaboration is not just in the research community. It affects a variety of social layers. Only a few of these layers include patients, patient family, numerous associations and non-governmental organizations, social scientists, healthcare professionals, social security institutions, political decision-makers, pharmaceutical companies, academics, etc.